Artículos de revistas sobre el tema "CSCs markers"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "CSCs markers".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Jaggupilli, Appalaraju y Eyad Elkord. "Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity". Clinical and Developmental Immunology 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/708036.
Texto completoLan, Linxiang y Axel Behrens. "Are There Specific Cancer Stem Cell Markers?" Cancer Research 83, n.º 2 (18 de enero de 2023): 170–72. http://dx.doi.org/10.1158/0008-5472.can-22-2053.
Texto completoHassan, Ghmkin, Said M. Afify, Neha Nair, Kazuki Kumon, Amira Osman, Juan Du, Hager Mansour et al. "Hematopoietic Cells Derived from Cancer Stem Cells Generated from Mouse Induced Pluripotent Stem Cells". Cancers 12, n.º 1 (29 de diciembre de 2019): 82. http://dx.doi.org/10.3390/cancers12010082.
Texto completoHassn Mesrati, Malak, Amir Barzegar Behrooz, Asmaa Y. Abuhamad y Amir Syahir. "Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer". Cells 9, n.º 5 (16 de mayo de 2020): 1236. http://dx.doi.org/10.3390/cells9051236.
Texto completoLee-Theilen, Mieun, Julia R. Hadhoud, Giulietta Volante, Delaine D. Fadini, Julia Eichhorn, Udo Rolle y Henning C. Fiegel. "Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG". Cells 10, n.º 10 (29 de septiembre de 2021): 2598. http://dx.doi.org/10.3390/cells10102598.
Texto completoLee, Shiao-Pieng, Pei-Ling Hsieh, Chih-Yuan Fang, Pei-Ming Chu, Yi-Wen Liao, Chuan-Hang Yu, Cheng-Chia Yu y Lo-Lin Tsai. "LINC00963 Promotes Cancer Stemness, Metastasis, and Drug Resistance in Head and Neck Carcinomas via ABCB5 Regulation". Cancers 12, n.º 5 (26 de abril de 2020): 1073. http://dx.doi.org/10.3390/cancers12051073.
Texto completoHarris, Koran S. y Bethany A. Kerr. "Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis". Stem Cells International 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8629234.
Texto completoGu, Yuanzhuo, Xin Zheng y Junfang Ji. "Liver cancer stem cells as a hierarchical society: yes or no?" Acta Biochimica et Biophysica Sinica 52, n.º 7 (3 de junio de 2020): 723–35. http://dx.doi.org/10.1093/abbs/gmaa050.
Texto completoDaya, Hiba Abou, Sana Kouba, Hakim Ouled-Haddou, Nazim Benzerdjeb, Marie-Sophie Telliez, Charles Dayen, Henri Sevestre, Loïc Garçon, Frédéric Hague y Halima Ouadid-Ahidouch. "Orai3-Mediates Cisplatin-Resistance in Non-Small Cell Lung Cancer Cells by Enriching Cancer Stem Cell Population through PI3K/AKT Pathway". Cancers 13, n.º 10 (12 de mayo de 2021): 2314. http://dx.doi.org/10.3390/cancers13102314.
Texto completoAlcalá, Sonia, Paola Martinelli, Patrick C. Hermann, Christopher Heeschen y Bruno Sainz. "The Anthrax Toxin Receptor 1 (ANTXR1) Is Enriched in Pancreatic Cancer Stem Cells Derived from Primary Tumor Cultures". Stem Cells International 2019 (2 de mayo de 2019): 1–13. http://dx.doi.org/10.1155/2019/1378639.
Texto completoWeaver, David T., Irina M. Shapiro, Alan G. Derr, Daniel Paterson y Jonathan A. Pachter. "Use of gene expression and alternative splicing signatures to discriminate breast cancer stem cells from fibroblasts." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): 1057. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1057.
Texto completoWu, Hsing-Ju y Pei-Yi Chu. "Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications". International Journal of Molecular Sciences 20, n.º 17 (25 de agosto de 2019): 4154. http://dx.doi.org/10.3390/ijms20174154.
Texto completoKumbar, Vijay M., Uday M. Muddapur, Kishore G. Bhat, Shwetha H.R., Manohar S. Kugaji y Malleswara Rao Peram. "Indirect Immunofluorescence and Tumorspheres Enrichment Technique for Identifying Cancer Stem Cell Markers in Cancer Cell Lines From Primary Oral Cancer Tissues: An In Vitro Study". Journal of Advanced Oral Research 11, n.º 2 (24 de julio de 2020): 224–30. http://dx.doi.org/10.1177/2320206820941379.
Texto completoSong, Jingwen, Yanrong Qian, Maria Evers, Corinne M. Nielsen y Xiaozhuo Chen. "Cancer Stem Cell Formation Induced and Regulated by Extracellular ATP and Stanniocalcin-1 in Human Lung Cancer Cells and Tumors". International Journal of Molecular Sciences 23, n.º 23 (25 de noviembre de 2022): 14770. http://dx.doi.org/10.3390/ijms232314770.
Texto completoMunro, Matthew J., Susrutha K. Wickremesekera, Lifeng Peng, Swee T. Tan y Tinte Itinteang. "Cancer stem cells in colorectal cancer: a review". Journal of Clinical Pathology 71, n.º 2 (23 de septiembre de 2017): 110–16. http://dx.doi.org/10.1136/jclinpath-2017-204739.
Texto completoShukla, Samriddhi, Sajid Khan, Sonam Sinha y Syed Musthapa Meeran. "Lung Cancer Stem Cells: An Epigenetic Perspective". Current Cancer Drug Targets 18, n.º 1 (8 de diciembre de 2017): 16–31. http://dx.doi.org/10.2174/1568009617666170206104623.
Texto completoLin, Kangyu y John Paul Shen. "Abstract 6066: Elucidating cancer stem cells heterogeneity in colorectal cancer by single-cell RNA sequencing". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 6066. http://dx.doi.org/10.1158/1538-7445.am2022-6066.
Texto completoZhang, Xiaoming, Ke Meng, Yujie Pu, Chao Wang, Yingying Chen y Linlin Wang. "Hyperglycemia Altered the Fate of Cardiac Stem Cells to Adipogenesis through Inhibiting the β-Catenin/TCF-4 Pathway". Cellular Physiology and Biochemistry 49, n.º 6 (2018): 2254–63. http://dx.doi.org/10.1159/000493828.
Texto completoBrescia, Paola, Cristina Richichi y Giuliana Pelicci. "Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?" Journal of Oncology 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/376894.
Texto completoPrayogo, Ami Ashariati, Andi Yasmin Wijaya, Winona May Hendrata, Steven Sheng Looi, Reny I’tishom, Lukman Hakim, Fedik Abdul Rantam, I. Ketut Sudiana y Abdurachman Abdurachman. "Dedifferentiation of MCF-7 Breast Cancer Continuous Cell Line, Development of Breast Cancer Stem Cells (BCSCs) Enriched Culture and Biomarker Analysis". Indonesian Biomedical Journal 12, n.º 2 (29 de junio de 2020): 115–23. http://dx.doi.org/10.18585/inabj.v12i2.977.
Texto completoOswald, James T., Haritosh Patel, Daid Khan, Ninweh N. Jeorje, Hossein Golzar, Erin L. Oswald y Shirley Tang. "Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells". Current Pharmaceutical Design 26, n.º 17 (7 de junio de 2020): 2057–71. http://dx.doi.org/10.2174/1381612826666200406084900.
Texto completoLee, Hwa-Yong y In-Sun Hong. "Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer". Cancers 12, n.º 10 (24 de septiembre de 2020): 2746. http://dx.doi.org/10.3390/cancers12102746.
Texto completoElkashty, Osama A., Ghada Abu Elghanam, Xinyun Su, Younan Liu, Peter J. Chauvin y Simon D. Tran. "Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas". Carcinogenesis 41, n.º 4 (19 de noviembre de 2019): 458–66. http://dx.doi.org/10.1093/carcin/bgz182.
Texto completoBadrinath, Narayanasamy y So Yoo. "Recent Advances in Cancer Stem Cell-Targeted Immunotherapy". Cancers 11, n.º 3 (5 de marzo de 2019): 310. http://dx.doi.org/10.3390/cancers11030310.
Texto completoTan, David, Imogen Roth, Agadha Wickremesekera, Paul Davis, Andrew Kaye, Theo Mantamadiotis, Stanley Stylli y Swee Tan. "Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System". Cells 8, n.º 11 (31 de octubre de 2019): 1364. http://dx.doi.org/10.3390/cells8111364.
Texto completoAfify, Said M., Ghmkin Hassan, Amira Osman, Anna Sanchez Calle, Hend M. Nawara, Maram Hussein Zahra, Samah EL-Ghlban et al. "Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma". Bioengineering 6, n.º 3 (23 de agosto de 2019): 73. http://dx.doi.org/10.3390/bioengineering6030073.
Texto completoCianciosi, Danila, Johura Ansary, Tamara Y. Forbes-Hernandez, Lucia Regolo, Denise Quinzi, Santos Gracia Villar, Eduardo Garcia Villena et al. "The Molecular Basis of Different Approaches for the Study of Cancer Stem Cells and the Advantages and Disadvantages of a Three-Dimensional Culture". Molecules 26, n.º 9 (29 de abril de 2021): 2615. http://dx.doi.org/10.3390/molecules26092615.
Texto completoHerreros-Pomares, Alejandro. "Identification, Culture and Targeting of Cancer Stem Cells". Life 12, n.º 2 (27 de enero de 2022): 184. http://dx.doi.org/10.3390/life12020184.
Texto completoCadilho, Julio Cesar Ramos, Silvia Maria de Carvalho Lyra, Ana Beatriz Machado Lima, Carina Maciel da Silva Boghossian y Cláudia Maria Pereira. "Stem cell markers expression evaluation in Oral Squamous Cell Carcinoma". Research, Society and Development 10, n.º 13 (14 de octubre de 2021): e314101320840. http://dx.doi.org/10.33448/rsd-v10i13.20840.
Texto completoMcCartin, Conor, Candice Dussouillez, Chloé Bernhard, Eric Mathieu, Juliette Blumberger, Monique Dontenwill, Christel Herold-Mende et al. "Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells". Cancers 14, n.º 20 (15 de octubre de 2022): 5057. http://dx.doi.org/10.3390/cancers14205057.
Texto completoYahaya, Badrul Hisham, Norashikin Zakaria, Noor Hanis Abu Halim y Nazilah Satar. "ID:3004 Lung cancer stem cell and its therapeutic potential". Biomedical Research and Therapy 4, S (5 de septiembre de 2017): 15. http://dx.doi.org/10.15419/bmrat.v4is.221.
Texto completoKobayashi, Natália Cristina Ciufa y Samuel Marcos Ribeiro de Noronha. "Cancer stem cells: a new approach to tumor development". Revista da Associação Médica Brasileira 61, n.º 1 (febrero de 2015): 86–93. http://dx.doi.org/10.1590/1806-9282.61.01.086.
Texto completode Kluyver, Rachel, Jim Stauffer, Alan Brooks, Anil Shanker y Tom Sayers. "Murine Hepatocellular Carcinoma Stem Cells Express Pluripotency-associated Transcription Factors and are Sensitive to Immune Mediated Apoptosis. (101.16)". Journal of Immunology 184, n.º 1_Supplement (1 de abril de 2010): 101.16. http://dx.doi.org/10.4049/jimmunol.184.supp.101.16.
Texto completoIbragimova, Marina, Matvey Tsyganov y Nikolai Litviakov. "Tumour Stem Cells in Breast Cancer". International Journal of Molecular Sciences 23, n.º 9 (2 de mayo de 2022): 5058. http://dx.doi.org/10.3390/ijms23095058.
Texto completoKoren, Ana, Matija Rijavec, Izidor Kern, Eva Sodja, Peter Korosec y Tanja Cufer. "BMI1,ALDH1A1, andCD133Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma". Stem Cells International 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/9714315.
Texto completoHuang, Binjie, Xin Yan y Yumin Li. "Cancer Stem Cell for Tumor Therapy". Cancers 13, n.º 19 (26 de septiembre de 2021): 4814. http://dx.doi.org/10.3390/cancers13194814.
Texto completoCheung, Sarah K. C., Po-Kai Chuang, Han-Wen Huang, Wendy W. Hwang-Verslues, Candy Hsin-Hua Cho, Wen-Bin Yang, Chia-Ning Shen et al. "Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells". Proceedings of the National Academy of Sciences 113, n.º 4 (17 de diciembre de 2015): 960–65. http://dx.doi.org/10.1073/pnas.1522602113.
Texto completoPozzi, Valentina, Davide Sartini, Romina Rocchetti, Andrea Santarelli, Corrado Rubini, Stefano Morganti, Rachela Giuliante et al. "Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines". Cellular Physiology and Biochemistry 36, n.º 2 (2015): 784–98. http://dx.doi.org/10.1159/000430138.
Texto completoQiu, Zhenghua, Lingjing Tu, Xiongwei Hu, Zhipeng Zhou, Yongwei Lin, Lili Ye y Chunhui Cui. "A Preliminary Study of miR-144 Inhibiting the Stemness of Colon Cancer Stem Cells by Targeting Krüppel-Like Factor 4". Journal of Biomedical Nanotechnology 16, n.º 7 (1 de julio de 2020): 1102–9. http://dx.doi.org/10.1166/jbn.2020.2952.
Texto completoHubbard, Joleen M. y Axel Grothey. "Cancer Stem Cells and Cancer Stem Cell Inhibitors in Gastrointestinal Cancers". Oncology & Hematology Review (US) 12, n.º 01 (2016): 41. http://dx.doi.org/10.17925/ohr.2016.12.01.41.
Texto completoMakki, Jaafar, Ohnmar Myint, Aye Aye Wynn, Ahmad Toha Samsudin y John Daisy Vanitha. "Expression Distribution of Cancer Stem Cells, Epithelial to Mesenchymal Transition, and Telomerase Activity in Breast Cancer and Their Association with Clinicopathologic Characteristics". Clinical Medicine Insights: Pathology 8 (enero de 2015): CPath.S19615. http://dx.doi.org/10.4137/cpath.s19615.
Texto completoKushwaha, Prem Prakash, Shiv Verma, Shashank Kumar y Sanjay Gupta. "Role of prostate cancer stem-like cells in the development of antiandrogen resistance". Cancer Drug Resistance 5, n.º 2 (2022): 459–71. http://dx.doi.org/10.20517/cdr.2022.07.
Texto completoLee-Theilen, Mieun, Delaine D. Fadini, Julia R. Hadhoud, Fleur van Dongen, Gabriela Kroll, Udo Rolle y Henning C. Fiegel. "Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy". Cancers 14, n.º 23 (25 de noviembre de 2022): 5825. http://dx.doi.org/10.3390/cancers14235825.
Texto completoBerber, Mohamed R., Hoda Elkhenany, Inas H. Hafez, Ahmed El-Badawy, Mohamed Essawy y Nagwa El-Badri. "Efficient tailoring of platinum nanoparticles supported on multiwalled carbon nanotubes for cancer therapy". Nanomedicine 15, n.º 8 (abril de 2020): 793–808. http://dx.doi.org/10.2217/nnm-2019-0445.
Texto completoGoto, Norihiro, Akihisa Fukuda, Yuichi Yamaga, Takaaki Yoshikawa, Takahisa Maruno, Hisatsugu Maekawa, Susumu Inamoto et al. "Lineage tracing and targeting of IL17RB+tuft cell-like human colorectal cancer stem cells". Proceedings of the National Academy of Sciences 116, n.º 26 (10 de junio de 2019): 12996–3005. http://dx.doi.org/10.1073/pnas.1900251116.
Texto completoKong, Byung Ho, Ju Hyung Moon, Yong-Min Huh, Jin-Kyoung Shim, Ji-Hyun Lee, Eui-Hyun Kim, Jong Hee Chang et al. "Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients". Stem Cells International 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/838950.
Texto completoPeired, Anna Julie, Alessandro Sisti y Paola Romagnani. "Renal Cancer Stem Cells: Characterization and Targeted Therapies". Stem Cells International 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/8342625.
Texto completoMinuk, Gerald Y., Wendy Bautista y Julianne Klein. "Evidence of Hepatitis B Virus Infection in Cancer and Noncancer Stem Cells Associated with Human Hepatocellular Carcinoma". Canadian Journal of Infectious Diseases and Medical Microbiology 2016 (2016): 1–4. http://dx.doi.org/10.1155/2016/8931591.
Texto completoSaito, Shigeo, Chia-Chen Ku, Kenly Wuputra, Jia-Bin Pan, Chang-Shen Lin, Ying-Chu Lin, Deng-Chyang Wu y Kazunari K. Yokoyama. "Biomarkers of Cancer Stem Cells for Experimental Research and Clinical Application". Journal of Personalized Medicine 12, n.º 5 (29 de abril de 2022): 715. http://dx.doi.org/10.3390/jpm12050715.
Texto completoAramini, Beatrice, Valentina Masciale, Giulia Grisendi, Federica Bertolini, Michela Maur, Giorgia Guaitoli, Isca Chrystel et al. "Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence". Cancers 14, n.º 4 (15 de febrero de 2022): 976. http://dx.doi.org/10.3390/cancers14040976.
Texto completo